arrow
M

Marco Battaglini

Department of Medicine
H指数:44
被引数:7,843

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis

血清神经丝轻链水平对多发性硬化最早阶段临床和影像学疾病进展的预测价值,超越MRI测量

2026-09-090
OAAI
Neurophysiological, imaging, and neurobiological markers of central fatigue in multiple sclerosis

多发性硬化中枢疲劳的神经生理学、影像学及神经生物学标志物

2026-04-160
OA
Machine learning for multiple sclerosis classification and disability prediction using clinical and MRI data

使用临床和MRI数据进行多发性硬化分类和残疾预测的机器学习

2026-04-100
OA
Linking movement-related beta oscillations to cortical excitability, structural damage, and fatigue in multiple sclerosis

将运动相关的β振荡与多发性硬化中的皮层兴奋性、结构损伤和疲劳联系起来

2026-03-120
OA
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort

特立氟胺和奥瑞利珠单抗对多发性硬化潜隐性活动比较效果:一项在瑞士多发性硬化队列中的观察性研究

2025-07-020
OAAI
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment
2024-09-013
OAAI
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
2024-05-231
OAAI
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

多发性硬化独立于复发的进展的决定因素和生物标志物

2024-04-0319
OA
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes

多发性硬化治疗前5年的疾病进展: 早期脑和病灶体积变化的预测价值

2023-11-290
OAAI
The spatio-temporal relationship between concurrent lesion and brain atrophy changes in early multiple sclerosis: A post-hoc analysis of the REFLEXION study

早期多发性硬化症并发病变与脑萎缩变化之间的时空关系: 反射研究的事后分析

2023-01-011
OAAI
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults
BRAIN
IF11.7
2022-12-1415
OA